AP |
action potentials |
APD |
AP duration |
ARDA |
Atrial selective therapeutic agents |
ChTx |
Charybdotoxin |
CMs |
cardiomyocytes |
EADs |
probability of early afterdepolarizations |
ERG |
ether-á-go-go gene |
ERP |
effective refractory period |
GOF |
gain of function |
hiAM |
human immortalized atrial myocyte |
iAM |
immortalized atrial myocyte |
IK,ACh
|
acetylcholine-sensitive inward rectifier potassium current |
IKr
|
rapidly activating |
IKs
|
slowly activating |
IKur
|
ultra-rapidly activating |
IL |
Interleukin |
Ito1
|
the “transient outward” potassium current |
Kv |
voltage-gated potassium channels |
KTx |
potassium channel toxins |
LOF |
loss of function |
MgTx |
Margatoxin |
PAH |
pulmonary arterial hypertension |
ProTx2 |
Protoxin II |
SPPS |
solid-phase peptide synthesis |
SR |
sinus rhythm |
TTX |
tetrodotoxin |
VGICs |
Voltage-gated ion channels |
Vmax
|
maximum speed of depolarization |
VSD |
voltage-sensing domain |
VSP |
voltage-sensing phosphatase |